BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 16, 2001
View Archived Issues
Amgen advances antibody into clinical trials, triggering milestone payment to Abgenix
Read More
SangStat enters into collaborations geared toward next-generation RDP-58 molecules
Read More
Licensing opportunity from NIH: immunostimulant LL-37
Read More
Vibrio cholerae O139 conjugate vaccines available for licensing from NIH
Read More
3M seeks additional FDA approval of QVAR
Read More
New Photofrin indication filed with Canadian authorities
Read More
Positive long-term survival and safety data reported for OvaRex
Read More
Idec submits additional information for Zevalin BLA
Read More
Macrophage aP2 as a target for therapy of atherosclerosis
Read More
Neutrophil elastase inhibitor prevents cancer metastasis in animal model
Read More
Direct factor Xa inhibitor DX-9065a shows promise for thrombosis and restenosis
Read More
Good safety, dose-proportional pharmacokinetics seen in early clinical trial of rPSGL-Ig
Read More
Ceprotin has beneficial therapeutic and prophylactic effects in protein C deficiency
Read More
FDA issues approvable letter for Natrecor
Read More
Identification, structure and biological activity of new glycoprotein trafficking inhibitor
Read More
Exelixis delivers cancer antibody targets to PDL for further development
Read More
Rational design of mesangial cell proliferation inhibitors
Read More
Microcide and Naeja to codevelop novel antifungal agents
Read More
Lexicon/Coelacanth merger complete
Read More
Excellent antibacterial profile demonstrated for HMR-3562 against enterococci
Read More
Olamufloxacin has high activity in murine models of systemic infections and UTIs
Read More
CDK-inhibitory quinazolines particularly useful for proliferative cardiovascular disorders
Read More
Cor's new anticoagulants presented in patent literature
Read More
Antiinflammatory compounds reported by Boehringer Ingelheim
Read More
Nontoxic MMP inhibitor from Pharmacia with antitumor activity
Read More
CXC chemokine inhibitors under development by French lab
Read More
Potent and selective antagonists of neuropeptide Y5 receptors identified at Shionogi
Read More
Enzo Biochem cleared to begin trial of immune regulation medicine for Crohn's disease
Read More